Jinxin Fertility Group (HK) Limited

Jinxin Fertility is an international professional service organisation in the field of assisted reproductive medicine, and is currently one of the largest non-public assisted reproductive medical groups with global influence in Mainland China. The company owns and operates Chengdu Xi’nan Gynecological Hospital, Shenzhen Zhongshan Urology Hospital, Wuhan Jinxin Gynecology and Obstetrics Hospital of Integrative Medicine, Yunnan Jinxin Jiuzhou Hospital and Kunming Jinxin Hewanjia Obstetrics And Gynecology Hospital in Mainland China; Hong Kong Reproductive Health Centre and Hong Kong Assisted Reproduction Centre in Hong Kong; HRC Assisted Reproductive Centre(Fertility Centre, Keck School of Medicine at the University of Southern California) in the United States; and Jinrui Medical Centre (HRC Southeast Asia Centre) in Laos.

With decades of development, Jinxin Fertility’s medical institutions have successfully increased assisted reproductive technology success rate, and enhanced patient experience and operational efficiency, and have accumulated a good reputation. In addition to its in-vitro-fertilisation (IVF) services, the company actively expands other value-added services in relation to assisted reproduction, and is committed to creating products and services for the whole cycle of assisted reproduction.